Skip to main content
Signal8

Morgon Pierre A.

SEC insider (Form 3/4/5 filer). CIK 0001851636. Director at Barinthus Biotherapeutics plc. (BRNS). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in GERMANTOWN, MD.

Companies Morgon Pierre A. has filed insider reports for

  • Barinthus Biotherapeutics plc. (BRNS): Director
Morgon Pierre A. profile photo

Morgon Pierre A.

CIK: 0001851636

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Barinthus Biotherapeutics plc. logo
BRNS

Barinthus Biotherapeutics plc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Barinthus Biotherapeutics plc. logo
    BRNS

    Barinthus Biotherapeutics plc.

    Sep 9, 2026
    Disposition
    Direct
    10.5K shares-
  • Barinthus Biotherapeutics plc. logo
    BRNS

    Barinthus Biotherapeutics plc.

    Jun 10, 2025
    Award

    Share Option (Right to Buy)

    Direct
    20.2K shares-

1-2 of 2